DKK 265.4
(2.47%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 22.44 Billion DKK | 13.89% |
2022 | 19.7 Billion DKK | 7.16% |
2021 | 18.38 Billion DKK | 27.09% |
2020 | 14.46 Billion DKK | -3.19% |
2019 | 14.94 Billion DKK | 7.24% |
2018 | 13.93 Billion DKK | 5.67% |
2017 | 13.18 Billion DKK | 9.89% |
2016 | 12 Billion DKK | 12.54% |
2015 | 10.66 Billion DKK | 14.11% |
2014 | 9.34 Billion DKK | 1.49% |
2013 | 9.2 Billion DKK | 7.64% |
2012 | 8.55 Billion DKK | 6.39% |
2011 | 8.04 Billion DKK | 16.66% |
2010 | 6.89 Billion DKK | 20.89% |
2009 | 5.7 Billion DKK | 6.09% |
2008 | 5.37 Billion DKK | -2.09% |
2007 | 5.48 Billion DKK | 7.93% |
2006 | 5.08 Billion DKK | 12.43% |
2005 | 4.52 Billion DKK | 5.12% |
2004 | 4.3 Billion DKK | 11.19% |
2003 | 3.86 Billion DKK | -1.38% |
2002 | 3.92 Billion DKK | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 5.54 Billion DKK | -51.15% |
2024 Q2 | 5.54 Billion DKK | 0.0% |
2023 FY | 22.44 Billion DKK | 13.89% |
2023 Q4 | 11.34 Billion DKK | 101.06% |
2023 Q3 | 5.64 Billion DKK | -49.61% |
2023 Q2 | 11.2 Billion DKK | 100.82% |
2023 Q1 | 5.57 Billion DKK | -44.83% |
2022 Q4 | 10.11 Billion DKK | 98.08% |
2022 Q3 | 5.1 Billion DKK | -45.66% |
2022 Q1 | 4.74 Billion DKK | -49.15% |
2022 Q2 | 9.39 Billion DKK | 97.81% |
2022 FY | 19.7 Billion DKK | 7.16% |
2021 Q1 | 4.37 Billion DKK | -47.82% |
2021 Q3 | 4.57 Billion DKK | -49.19% |
2021 Q4 | 9.33 Billion DKK | 103.93% |
2021 Q2 | 9.01 Billion DKK | 106.11% |
2021 FY | 18.38 Billion DKK | 27.09% |
2020 Q1 | 3.03 Billion DKK | -59.99% |
2020 Q2 | 6.1 Billion DKK | 100.72% |
2020 Q3 | 4.19 Billion DKK | -31.22% |
2020 Q4 | 8.38 Billion DKK | 99.76% |
2020 FY | 14.46 Billion DKK | -3.19% |
2019 Q1 | 3.67 Billion DKK | 2.65% |
2019 FY | 14.94 Billion DKK | 7.24% |
2019 Q2 | 7.35 Billion DKK | 100.0% |
2019 Q3 | 3.79 Billion DKK | -48.33% |
2019 Q4 | 7.59 Billion DKK | 100.0% |
2018 Q3 | 3.58 Billion DKK | 5.65% |
2018 Q1 | 3.38 Billion DKK | 1.39% |
2018 Q4 | 3.58 Billion DKK | 0.0% |
2018 FY | 13.93 Billion DKK | 5.67% |
2018 Q2 | 3.38 Billion DKK | 0.0% |
2017 FY | 13.18 Billion DKK | 9.89% |
2017 Q4 | 3.34 Billion DKK | 0.0% |
2017 Q3 | 3.34 Billion DKK | 2.75% |
2017 Q2 | 3.25 Billion DKK | 0.0% |
2017 Q1 | 3.25 Billion DKK | 5.05% |
2016 Q1 | 2.9 Billion DKK | 3.34% |
2016 Q2 | 2.9 Billion DKK | 0.0% |
2016 Q3 | 3.09 Billion DKK | 6.57% |
2016 FY | 12 Billion DKK | 12.54% |
2016 Q4 | 3.09 Billion DKK | 0.0% |
2015 FY | 10.66 Billion DKK | 14.11% |
2015 Q4 | 2.81 Billion DKK | 0.0% |
2015 Q3 | 2.81 Billion DKK | 11.48% |
2015 Q2 | 2.52 Billion DKK | 0.0% |
2015 Q1 | 2.52 Billion DKK | 4.91% |
2014 Q4 | 2.4 Billion DKK | 0.0% |
2014 Q3 | 2.4 Billion DKK | 5.9% |
2014 Q1 | 2.26 Billion DKK | -0.37% |
2014 FY | 9.34 Billion DKK | 1.49% |
2014 Q2 | 2.26 Billion DKK | 0.0% |
2013 FY | 9.2 Billion DKK | 7.64% |
2013 Q4 | 2.27 Billion DKK | 0.0% |
2013 Q3 | 2.27 Billion DKK | 3.47% |
2013 Q2 | 2.2 Billion DKK | 0.0% |
2013 Q1 | 2.2 Billion DKK | 2.47% |
2012 Q1 | 2.13 Billion DKK | 6.39% |
2012 Q2 | 2.13 Billion DKK | 0.0% |
2012 FY | 8.55 Billion DKK | 6.39% |
2012 Q3 | 2.14 Billion DKK | 0.46% |
2012 Q4 | 2.14 Billion DKK | 0.0% |
2011 Q1 | 2.01 Billion DKK | 16.66% |
2011 Q4 | 2.01 Billion DKK | 0.0% |
2011 FY | 8.04 Billion DKK | 16.66% |
2011 Q3 | 2.01 Billion DKK | 0.0% |
2011 Q2 | 2.01 Billion DKK | 0.0% |
2010 Q4 | 1.72 Billion DKK | 0.0% |
2010 Q2 | 1.72 Billion DKK | 0.0% |
2010 Q3 | 1.72 Billion DKK | 0.0% |
2010 Q1 | 1.72 Billion DKK | 20.89% |
2010 FY | 6.89 Billion DKK | 20.89% |
2009 FY | 5.7 Billion DKK | 6.09% |
2009 Q1 | 1.42 Billion DKK | 6.09% |
2009 Q2 | 1.42 Billion DKK | 0.0% |
2009 Q3 | 1.42 Billion DKK | 0.0% |
2009 Q4 | 1.42 Billion DKK | 0.0% |
2008 FY | 5.37 Billion DKK | -2.09% |
2008 Q4 | 1.34 Billion DKK | 0.0% |
2008 Q3 | 1.34 Billion DKK | 0.0% |
2008 Q2 | 1.34 Billion DKK | 0.0% |
2008 Q1 | 1.34 Billion DKK | -2.09% |
2007 Q4 | 1.37 Billion DKK | 0.0% |
2007 Q3 | 1.37 Billion DKK | 0.0% |
2007 FY | 5.48 Billion DKK | 7.93% |
2007 Q2 | 1.37 Billion DKK | 0.0% |
2007 Q1 | 1.37 Billion DKK | 7.93% |
2006 Q2 | 1.27 Billion DKK | 0.0% |
2006 Q3 | 1.27 Billion DKK | 0.0% |
2006 Q4 | 1.27 Billion DKK | 0.0% |
2006 Q1 | 1.27 Billion DKK | 12.43% |
2006 FY | 5.08 Billion DKK | 12.43% |
2005 Q1 | 1.13 Billion DKK | 5.12% |
2005 Q4 | 1.13 Billion DKK | 0.0% |
2005 FY | 4.52 Billion DKK | 5.12% |
2005 Q3 | 1.13 Billion DKK | 0.0% |
2005 Q2 | 1.13 Billion DKK | 0.0% |
2004 Q1 | 1.07 Billion DKK | 11.19% |
2004 Q2 | 1.07 Billion DKK | 0.0% |
2004 FY | 4.3 Billion DKK | 11.19% |
2004 Q3 | 1.07 Billion DKK | 0.0% |
2004 Q4 | 1.07 Billion DKK | 0.0% |
2003 Q1 | 967.42 Million DKK | -1.38% |
2003 FY | 3.86 Billion DKK | -1.38% |
2003 Q4 | 967.42 Million DKK | 0.0% |
2003 Q3 | 967.42 Million DKK | 0.0% |
2003 Q2 | 967.42 Million DKK | 0.0% |
2002 Q4 | 980.91 Million DKK | 0.0% |
2002 FY | 3.92 Billion DKK | 0.0% |
2002 Q1 | 980.91 Million DKK | 0.0% |
2002 Q2 | 980.91 Million DKK | 0.0% |
2002 Q3 | 980.91 Million DKK | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Ambu A/S | 5.39 Billion DKK | -316.305% |
ChemoMetec A/S | 407.87 Million DKK | -5402.489% |
GN Store Nord A/S | 18.12 Billion DKK | -23.858% |
Scandinavian Medical Solutions A/S | 191.19 Million DKK | -11638.488% |
ViroGates A/S | 6.98 Million DKK | -321110.82% |